Abstract
Oxidative stress plays a role in the pathogenesis of bone loss, causing low bone mineral density (BMD) and associated osteoporotic fractures. In our study, we aimed to investigate the relationship of SOD1 50-bp insertion(Ins)/deletion(Del) polymorphism that is involved in oxidative stress metabolism, Cu and Zn element concentrations, and plasma viscosity level, with postmenopausal osteoporosis and related vertebral fractures. The study included 167 voluntary individuals. The 50-bp Ins/Del polymorphism of SOD1 was determined by allele-specific PCR. Plasma Cu and Zn levels were measured by atomic absorption spectrophotometry (AAS). The plasma viscosity was determined using the Harkness Capillary Viscometer device. In our study, the distribution of SOD1 promoter 50-bp Ins/Del polymorphism did not indicate a significant difference between the groups and in postmenopausal osteoporosis patients with and without fractures (p > 0.05). The Ins/Ins genotype was found to be common in individuals in both groups. The Cu and Zn levels of the study group were found to be between the normal reference values (p > 0.05). It was determined that plasma viscosity increased significantly in the group of osteoporotic patients and in patients with postmenopausal osteoporosis with fractures (p < 0.01). In addition, plasma viscosity was found to significantly increase in patients with Ins/Ins genotype and fractures (p < 0.01). Postmenopausal osteoporosis and associated vertebral fracture were found not to be directly related to SOD1 50-bp polymorphism and Cu and Zn element levels. Plasma viscosity levels were found to increase due to the increase in oxidative stress products. Further studies are needed to clarify the roles and relationships of SOD genes and trace elements in the development of postmenopausal osteoporosis and vertebral fracture.
Similar content being viewed by others
References
Kanis JA, Delmas P, Burckhardt P, Cooper C, Torgerson D (1997) Guidelines for diagnosis and management of osteoporosis. Osteoporos Int 7:390–406
Pouresmaeili F, Kamalidehghan B, Kamarehei M, Goh YM (2018) A comprehensive overview on osteoporosis and its risk factors. Ther Clin Risk Manag 14:2029
Sözen T, Özışık L, Başaran NÇ (2017) An overview and management of osteoporosis. Eur J Rheumatol 4:46
Barnsley J, Buckland G, Chan PE, Ong A, Ramos AS, Baxter M, Laskou F, Dennison EM, Cooper C, Patel HP (2021) Pathophysiology and treatment of osteoporosis: challenges for clinical practice in older people. Aging Clin Exp Res 33:759–773
Ferrari S (2005) Osteoporosis: a complex disorder of aging with multiple genetic and environmental determinants. World Rev Nutr Diet 95:35
Botre C, Shahu A, Adkar N, Shouche Y, Ghaskadbi S, Ashma R (2015) Superoxide dismutase 2 polymorphisms and osteoporosis in Asian Indians: a genetic association analysis. Cell Mol Biol Lett 20:685–697
Lean JM, Davies JT, Fuller K, Jagger CJ, Kirstein B, Partington GA, Urry ZL, Chambers TJ (2003) A crucial role for thiol antioxidants in estrogen-deficiency bone loss. J Clin Invest 112:915–923
Baek KH, Oh KW, Lee WY, Lee SS, Kim MK, Kwon HS, Rhee EJ, Han JH, Song KH, Cha BY (2010) Association of oxidative stress with postmenopausal osteoporosis and the effects of hydrogen peroxide on osteoclast formation in human bone marrow cell cultures. Calcif Tissue Int 87:226–235
Agidigbi TS, Kim C (2019) Reactive oxygen species in osteoclast differentiation and possible pharmaceutical targets of ROS-mediated osteoclast diseases. Int J Mol Sci 20:3576
Basu S, Michaëlsson K, Olofsson H, Johansson S, Melhus H (2001) Association between oxidative stress and bone mineral density. Biochem Biophys Res Commun 288:275–279
Fukai T, Ushio-Fukai M (2011) Superoxide dismutases: role in redox signaling, vascular function, and diseases. Antioxid Redox Signal 15:1583–1606
Juarez JC, Manuia M, Burnett ME, Betancourt O, Boivin B, Shaw DE, Tonks NK, Mazar AP, Doñate F (2008) Superoxide dismutase 1 (SOD1) is essential for H2O2-mediated oxidation and inactivation of phosphatases in growth factor signaling. Proc Natl Acad Sci 105:7147–7152
Carlström M, Lai EY, Ma Z, Steege A, Patzak A, Eriksson UJ, Lundberg JO, Wilcox CS, Persson AEG (2010) Superoxide dismutase 1 limits renal microvascular remodeling and attenuates arteriole and blood pressure responses to angiotensin II via modulation of nitric oxide bioavailability. Hypertension 56:907–913
Neves AL, Mohammedi K, Emery N, Roussel R, Fumeron F, Marre M, Velho G (2012) Allelic variations in superoxide dismutase-1 (SOD1) gene and renal and cardiovascular morbidity and mortality in type 2 diabetic subjects. Mol Genet Metab 106:359–365
Milani P, Gagliardi S, Bongioanni P, Grieco GS, Dezza M, Bianchi M, Cova E, Ceroni M, Cereda C (2012) Effect of the 50 bp deletion polymorphism in the SOD1 promoter on SOD1 mRNA levels in Italian ALS patients. J Neurol Sci 313:75–78
Milani P, Gagliardi S, Cova E, Cereda C (2011) SOD1 transcriptional and posttranscriptional regulation and its potential implications in ALS. Neurol Res Int 1:1–9
Nojiri H, Saita Y, Morikawa D, Kobayashi K, Tsuda C, Miyazaki T, Saito M, Marumo K, Yonezawa I, Kaneko K (2011) Cytoplasmic superoxide causes bone fragility owing to low-turnover osteoporosis and impaired collagen cross-linking. J Bone Miner Res 26:2682–2694
Morikawa D, Nojiri H, Saita Y, Kobayashi K, Watanabe K, Ozawa Y, Koike M, Asou Y, Takaku T, Kaneko K (2013) Cytoplasmic reactive oxygen species and SOD1 regulate bone mass during mechanical unloading. J Bone Miner Res 28:2368–2380
Mlakar SJ, Osredkar J, Prezelj J, Marc J (2012) Antioxidant enzymes GSR, SOD1, SOD2, and CAT gene variants and bone mineral density values in postmenopausal women: a genetic association analysis. Menopause 19:368–376
Deng F, Lei S, Chen X, Tan L, Zhu X, Deng H (2011) An integrative study ascertained SOD2 as a susceptibility gene for osteoporosis in Chinese. J Bone Miner Res 26:2695–2701
Sarabandi S, Effatpanah H, Sereshki N, Samavarchi Tehrani S, Moradi-Sardareh H (2021) 50-bp insertion/deletion polymorphism of the superoxide dismutase-1 is associated with bladder cancer risk in an Iranian population. Nucleosides Nucleotides Nucleic Acids 1–12
Namdari S, Saadat M (2021) Susceptibility to preeclampsia is associated with a 50-bp insertion/deletion polymorphism at the promoter region of the SOD1 gene. J Turkish Ger Gynecol Assoc 22:268
Eskandari-Nasab E, Kharazi-Nejad E, Nakhaee A, Afzali M, Tabatabaei SP, Tirgar-Fakheri K, Hashemi M (2014) 50-bp Ins/Del polymorphism of SOD1 is associated with increased risk of cardiovascular disease. Acta Med Iran 52:591–595
Kordestanian N, Saadat M (2017) A 50-bp Ins/Del polymorphism at the promoter region of the superoxide dismutase-1 and bipolar disorder type 1. Nord J Psychiatry 71:570–573
Aaseth J, Boivin G, Andersen O (2012) Osteoporosis and trace elements–an overview. J Trace Elem Med Biol 26:149–152
Moioli C, Tagliabue L, Cioni F (2018) Osteoporosis and mineral nutrition. A literature review. Prog Nutr 20:305–312
Saltman PD, Strause LG (1993) The role of trace minerals in osteoporosis. J Am Coll Nutr 12:384–389
Liu S-Z, Yan H, Xu P, Li J-P, Zhuang G-H, Zhu B-F, Lu S-M (2009) Correlation analysis between bone mineral density and serum element contents of postmenopausal women in Xi’an urban area. Biol Trace Elem Res 131:205–214
Nieves JW (2005) Osteoporosis: the role of micronutrients. Am J Clin Nutr 81:1232S-1239S
Strain JJ (1988) A reassessment of diet and osteoporosis—possible role for copper. Med Hypotheses 27:333–338
Relea P, Revilla M, Ripoll E, Arribas I, Villa LF, Rico H (1995) Zinc, biochemical markers of nutrition, and type I osteoporosis. Age Ageing 24:303–307
Arikan DC, Coskun A, Ozer A, Kilinc M, Atalay F, Arikan T (2011) Plasma selenium, zinc, copper and lipid levels in postmenopausal Turkish women and their relation with osteoporosis. Biol Trace Elem Res 144:407–417
Cervellati C, Bergamini CM (2016) Oxidative damage and the pathogenesis of menopause related disturbances and diseases. Clin Chem Lab Med 54:739–753
Harisa GI (2015) Blood viscosity as a sensitive indicator for paclitaxel induced oxidative stress in human whole blood. Saudi Pharm J 23:48–54
Bajada S, Yoong AWH, Hourigan P, Koopmans PC, Phillips JRA, Toms AD (2019) Plasma viscosity has a role in the diagnosis of prosthetic joint infection after total knee arthroplasty. J Arthroplasty 34:3035–3039
Teng Z, Pei L, Zhang Y, Li Y, Wang R (2013) Whole blood viscosity is negatively associated with bone mineral density in postmenopausal women with osteoporosis. Bone 56:343–346
Miller SA, Dykes DD, Polesky H (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
Ozcelik D, Tuncdemir M, Ozturk M, Uzun H (2011) Evaluation of trace elements and oxidative stress levels in the liver and kidney of streptozotocin-induced experimental diabetic rat model. Gen Physiol Biophys 30:356–363
Alkan FA, Cakmak G, Karis D, Sağlam ZA, Saler T, Temiz LU, Yenigün M, Ercan M (2014) The evaluation of plasma viscosity and endothelial dysfunction in smoking individuals. Clin Hemorheol Microcirc 58:403–413
Miao L, Clair DKS (2009) Regulation of superoxide dismutase genes: implications in disease. Free Radic Biol Med 47:344–356
Nielsen FH, Lukaski HC, Johnson LK, Roughead ZKF (2011) Reported zinc, but not copper, intakes influence whole-body bone density, mineral content and T score responses to zinc and copper supplementation in healthy postmenopausal women. Br J Nutr 106:1872–1879
Sadeghi N, Oveisi MR, Jannat B, Hajimahmoodi M, Behzad M, Behfar A, Sadeghi F, Saadatmand S (2014) The relationship between bone health and plasma zinc, copper lead and cadmium concentration in osteoporotic women. J Environ Heal Sci Eng 12:1–5
Rajeswaran C, Spencer J, Barth JH, Orme SM (2007) Utility of biochemical screening in the context of evaluating patients with a presumptive diagnosis of osteoporosis. Clin Rheumatol 26:362–365
Author information
Authors and Affiliations
Contributions
Designed the study: A.S., F.D.; collected samples: M.O.; determined polymorphism: F.D., D.T.C., and A.S.; measured element: MB; measured viscosity: A.S., D.D.E.; all authors read and approved the final version of the manuscript.
Corresponding author
Ethics declarations
Ethical Approval
The study protocol complied with the ethical guideline for the 2013 Declaration of Helsinki and was approved by the Istanbul Aydin University Ethical Committee (Ethic No: B.30.2.AYD.0.00.00–050.06.04/590).
Conflict of Interest
The authors declare no competing interests.
Additional information
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Soyocak, A., Doganer, F., Duzgun Ergun, D. et al. Evaluation of Relationship Between SOD1 50-bp Deletion Gene Polymorphism, Cu, Zn Level, and Viscosity in Postmenopausal Osteoporosis Patients with Vertebral Fractures. Biol Trace Elem Res 201, 603–610 (2023). https://doi.org/10.1007/s12011-022-03185-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12011-022-03185-8